IDH1/IDH2 Inhibition in Acute Myeloid Leukemia
Sign Up to like & getrecommendations! Published in 2021 at "Frontiers in Oncology"
DOI: 10.3389/fonc.2021.639387
Abstract: Recently, the discovery of biological and clinical properties of mutated isoforms 1 and 2 mutations of isocitrate dehydrogenases (IDH) 1 and 2, affecting approximately 20% of patients with acute myeloid leukemia (AML), lead to the… read more here.
Keywords: idh1 idh2; myeloid leukemia; idh2 inhibition; acute myeloid ... See more keywords